Harmony Biosciences Holdings, Inc. (HRMY) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Plymouth Meeting, PA, 美国. 现任CEO为 Jeffrey Dayno.
HRMY 拥有 IPO日期为 2020-08-19, 268 名全职员工, 在 NASDAQ Global Market, 市值为 $1.69B.
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
